abstract |
The invention belongs to the field of biomedicine, and particularly relates to a marker combination and its application in diagnosing pancreaticobiliary tract cancer. Specifically, the present invention provides a marker combination, the marker combination includes a methylation marker and a gene mutation, and the methylation marker includes SOX17, 3-OST-2, NXPH1, SEPT9 and TERT one or more of them. |